Mitesh

/Mitesh

About Mitesh

This author has not yet filled in any details.
So far Mitesh has created 276 blog entries.

Class 4 Medicines Defect Notification: Amitriptyline hydrochloride 10mg, 25mg, 50mg tablets (Flamingo Pharma UK Ltd)

MHRA Class 4 Medicines Defect Notification: Amitriptyline hydrochloride 10mg, 25mg, 50mg tablets (Flamingo Pharma UK Ltd) Drug alert number: EL(25)A/52 Date issued: 10 December 2025 Flamingo Pharma UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information. DMRC reference [...]

The post Class 4 Medicines Defect Notification: Amitriptyline hydrochloride 10mg, 25mg, 50mg tablets (Flamingo Pharma UK Ltd) appeared first on Community Pharmacy England.

By |December 10th, 2025|Lexpos News|Comments Off on Class 4 Medicines Defect Notification: Amitriptyline hydrochloride 10mg, 25mg, 50mg tablets (Flamingo Pharma UK Ltd)

Funding & Reimbursement Shorts: Disallowed items

As part of our Funding & Reimbursement Shorts  series, Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video on disallowed items. Disallowed items are those that have not been passed for payment by the NHS Business Services Authority (NHSBSA). It is important that pharmacy teams understand what can be done avoid [...]

The post Funding & Reimbursement Shorts: Disallowed items appeared first on Community Pharmacy England.

By |December 3rd, 2025|Lexpos News|Comments Off on Funding & Reimbursement Shorts: Disallowed items

Expiry of SSP077 (Cefalexin 125mg/5ml oral suspension sugar free) & SSP078 (Cefalexin 250mg/5ml oral suspension sugar free)

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Cefalexin 125mg/5ml oral suspension sugar free and Cefalexin 250mg/5ml oral suspension sugar free is now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP077 Cefalexin 125mg/5ml oral suspension sugar free and SSP078 Cefalexin 250mg/5ml oral suspension [...]

The post Expiry of SSP077 (Cefalexin 125mg/5ml oral suspension sugar free) & SSP078 (Cefalexin 250mg/5ml oral suspension sugar free) appeared first on Community Pharmacy England.

By |November 28th, 2025|Lexpos News|Comments Off on Expiry of SSP077 (Cefalexin 125mg/5ml oral suspension sugar free) & SSP078 (Cefalexin 250mg/5ml oral suspension sugar free)

Class 4 Medicines Defect Notification: Moclobemide 150mg tablets (Lexon UK Ltd)

MHRA Class 4 Medicines Defect Notification: Moclobemide 150mg tablets (Lexon UK Ltd) Drug alert number: EL(25)A/50 Date issued: 25 November 2025 Lexon UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification is missing important updated safety information. DMRC reference number: DMRC – 37693641 [...]

The post Class 4 Medicines Defect Notification: Moclobemide 150mg tablets (Lexon UK Ltd) appeared first on Community Pharmacy England.

By |November 25th, 2025|Lexpos News|Comments Off on Class 4 Medicines Defect Notification: Moclobemide 150mg tablets (Lexon UK Ltd)

Ministry of Defence (MOD) using paper FP10 prescriptions

The Department of Health and Social Care (DHSC) has announced that from the start of 2026, the Ministry of Defence (MOD) will start using paper FP10 prescription forms for all outsourced prescriptions issued by MOD medical facilities. Any MOD-issued paper FP10 prescriptions should be processed by pharmacy teams in the usual way. The small number of MOD-issued [...]

The post Ministry of Defence (MOD) using paper FP10 prescriptions appeared first on Community Pharmacy England.

By |November 21st, 2025|Lexpos News|Comments Off on Ministry of Defence (MOD) using paper FP10 prescriptions